Fundraising Fox

HVR Cardio

Founded 2009 · 2 known investors

hvrcardio.com ↗

HVR Cardio develops the CathHELIX transcatheter mitral valve repair system, a device that reduces the mitral annulus and deploys a self-securing ring to reshape the annulus and restore native leaflet function. The technology is intended as a minimally invasive alternative to surgical mitral valve repair for treating mitral valve regurgitation.

HardwareHealthtechMedical Devices

Investors · 2

IndustrifondenStockholm · $1.1M – $4.3M
InnovestorreportedFinland

In the news

HVR Cardio closes €10.7 million series B funding roundcardiovascularnews.com · Jan 2023HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND'S INNOVESTOR LIFE SCIENCE FUND AND TESIprnewswire.com · Jan 2023HVR Cardio Raised $11.1M in Series B Financingfinsmes.com · Jan 2023HVR Cardio Raises Series B Funding and Introduces New Leadership Team - Cardiac Interventions Todaycitoday.com · Jan 2023Innovestor leads the funding round of HVR Cardio, a Finnish cardiovascular device company - Innovestorinnovestorgroup.com · Jan 2023HVR Cardio Raises €8M in New Financing Round - HVR Cardiohvrcardio.com · Nov 2015

Frequently asked questions

What does HVR Cardio do?
HVR Cardio develops the CathHELIX transcatheter mitral valve repair system, a device that reduces the mitral annulus and deploys a self-securing ring to reshape the annulus and restore native leaflet function. The technology is intended as a minimally invasive alternative to surgical mitral valve repair for treating mitral valve regurgitation.
Who are HVR Cardio's investors?
HVR Cardio's investors include Industrifonden, Innovestor.